Like a great orchestra, your brain relies on the perfect coordination of many elements to function properly. And if one of those elements is out of sync, it affects the entire ensemble. In Alzheimer’s disease, for instance, damage to specific neurons can alter brainwave rhythms and cause a loss of cognitive functions.
One type of neuron, called inhibitory interneuron, is particularly important for managing brain rhythms. It’s also the research focus of a laboratory led by Jorge Palop, PhD, assistant investigator at the Gladstone Institutes. In a study published in Neuron, Palop and his collaborators uncovered the therapeutic benefits of genetically improving these interneurons and transplanting them into the brain of a mouse model of Alzheimer’s disease.
Interneurons control complex networks between neurons, allowing them to send signals to one another in a harmonized way. You can think of inhibitory interneurons as orchestra conductors. They create rhythms in the brain to instruct the players—excitatory neurons—when to play and when to stop. An imbalance between these two types of neurons creates disharmony and is seen in multiple neurological and psychiatric disorders, including Alzheimer’s disease, epilepsy, schizophrenia, and autism.
A Brain without a Conductor
Palop’s previous studies showed that, in mouse models of Alzheimer’s, the inhibitory interneurons do not work properly. So, the rhythms that organize the excitatory cells are disturbed and fail to function harmoniously, causing an imbalance in brain networks. This, in turn, affects memory formation and can lead to epileptic activity, which is often observed in patients with Alzheimer’s disease.
His team found a way to reengineer inhibitory interneurons to improve their function. They showed that these enhanced interneurons, when transplanted into the abnormal brain of Alzheimer mice, can properly control the activity of excitatory cells and restore brain rhythms.
“We took advantage of the fact that transplanted interneurons can integrate remarkably well into new brain tissues, and that each interneuron can control thousands of excitatory neurons,” said Palop, who is also an assistant professor of neurology at the University of California, San Francisco. “These properties make interneurons a promising therapeutic target for cognitive disorders associated with brain rhythm abnormalities and epileptic activity.”
First, the scientists had to overcome a significant challenge. When they transplanted regular interneurons, they saw no beneficial effects, presumably because Alzheimer’s disease creates a toxic environment in the brain.
The researchers then genetically boosted the activity of inhibitory interneurons by adding a protein called Nav1.1. They discovered that the interneurons with enhanced function were able to overcome the toxic disease environment and restore brain function.
“These optimized neurons are like master conductors,” said Palop. “Even with a declining orchestra, they can restore the rhythms and harmony needed for cognitive functions.”
Conductors Engineered for Alzheimer’s Disease
The findings could eventually lead to the development of new treatment options for patients with Alzheimer’s disease.
“Besides the applications this cell engineering and transplantation approach may find in regenerative medicine, our findings support the broader concept that enhancing the function of interneurons can counteract key aspects of Alzheimer’s disease,” said Lennart Mucke, MD, director of the Gladstone Institute of Neurological Disease.
In addition to examining if the cell therapy could be translated from mice to humans, Palop and his team are working to identify potential drugs as an alternative way to enhance the function of inhibitory interneurons.
The Latest on: Alzheimer’s Disease
via Google News
The Latest on: Alzheimer’s Disease
- Memory tests predict brain atrophy and Alzheimer's disease on December 10, 2018 at 8:36 am
Use of two episodic memory tests help in predicting brain atrophy and Alzheimer's disease, as indicated by a study. Researchers suggest that comprehensive use of memory tests could improve the diagnos... […]
- Sure, you can learn your genetic risk for Alzheimer's. But do you really want to know? on December 10, 2018 at 6:54 am
Even a couple of decades ago, the role that genetics plays in Alzheimer's disease was still largely a mystery. But times have changed. Today, you can write a check, send a sample of your saliva to a p... […]
- Johns Hopkins Team Identifies Promising Diagnostic Tool For Alzheimer’s Disease on December 10, 2018 at 6:36 am
Newswise — Researchers at Johns Hopkins Medicine have identified in live human brains new radioactive “tracer” molecules that bind to and “light up” tau tangles, a protein associated with a number of ... […]
- Promising diagnostic tool for Alzheimer's disease on December 10, 2018 at 6:26 am
Researchers have identified in live human brains new radioactive 'tracer' molecules that bind to and 'light up' tau tangles, a protein associated with a number of neurodegenerative diseases including ... […]
- Aging Research May Hold Key to New Alzheimer’s Treatments on December 10, 2018 at 5:53 am
A full review of Alzheimer’s drug research, including current agents being studied for the prevention and treatment of the disease (and other dementias), emphasizes the need to develop and test ... […]
- Eisai, UCL to launch phase I trials of E2814 for Alzheimer’s disease on December 10, 2018 at 2:21 am
Eisai said that the first investigational drug candidate from its drug discovery collaboration with University College London (UCL) is set to enter Phase I clinical trials for Alzheimer's disease (AD) ... […]
- Hartford police locate missing woman who suffers from Alzheimer's on December 9, 2018 at 8:37 pm
Police said Garcia left her McKinley Street home shortly before noon Sunday without saying where she was going. She suffers from Alzheimer’s disease and has high blood pressure. Garcia was found safe, ... […]
- He had power of attorney over his Alzheimer’s-afflicted mother — and stole $332,000, grand jury says on December 9, 2018 at 11:05 am
For nearly four years, John Jerome O’Hara took charge of his mother’s care at a Kentucky nursing home as Alzheimer’s disease robbed her of independence. O’Hara gained power of attorney over her affair... […]
- After marijuana edibles helped dying Holocaust survivor battle Alzheimer's, his family's foundation pushes for more research on December 9, 2018 at 10:50 am
By contrast, THC worsened brain function in young mice. More promising for Alzheimer’s disease, animal research has also shown that THC may increase the neurotransmitter acetylcholine ... […]
via Bing News